Leão GS, et al. - Using MEDLINE and Embase databases, researchers conducted a systematic review to compare the albumin use associated with antibiotics and antibiotics alone in cirrhotic patients with extraperitoneal infections. Randomized controlled trials were considered eligible, as long as at least one of the following outcomes was assessed: mortality and renal dysfunction. According to findings, the use of albumin in cirrhotic patients with extraperitoneal infections in mortality or renal dysfunction does not show any significant benefits.